# A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy

> **NCT07135219** · EARLY_PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Peking University First Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Immunoglobulin A Nephropathy (IgAN)

## Interventions

- **DRUG:** Biological: cizutamig

## Key facts

- **NCT ID:** NCT07135219
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-07-16
- **Primary completion:** 2025-12
- **Final completion:** 2027-01
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07135219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07135219, "A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07135219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*